Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography

Table 3 Association of various parameters with the presence of radiation retinopathy in irradiated eyes

		Radiation Retinopathy		Odds Ratio (Confidence Interval 95%)	P-value†
		Yes (n = 16)	No (n = 6)	Odds Ratio (Confidence Interval 95%)	P-value†
Age		51.75 ± 14.11	49.00 ± 16.68	1.013 (0.956–1.074)	0.654
Foveal thickness μm		319 ± 166	237 ± 64	1.004 (0.996–1.012)	0.319
FAZ mm²	Superficial	1775 ± 2127	311 ± 262	1.005 (0.993–1.016)	0.411
FAZ mm²	Deep	2023 ± 2303	168 ± 74	1.019 (0.983–1.055)	0.306
Superficial vascular area density %	Fovea	20.75 ± 8.72	26.14 ± 6.15	0.913 (0.798–1.044)	0.183
Superficial vascular area density %	Parafovea	21.98 ± 9.85	27.70 ± 6.54	0.925 (0.820–1.043)	0.204
Deep vascular area density %	Fovea	22.23 ± 9.94	25.99 ± 7.80	0.955 (0.859–1.062)	0.397
Deep vascular area density %	Parafovea	23.20 ± 10.43	27.19 ± 8.50	0.957 (0.865–1.059)	0.396
Superficial vascular skeleton density %	Fovea	7.76 ± 3.65	9.95 ± 2.29	0.806 (0.585–1.111)	0.189
Superficial vascular skeleton density %	Parafovea	8.16 ± 4.12	10.49 ± 2.50	0.834 (0.627–1.108)	0.210
Deep vascular skeleton density %	Fovea	9.51 ± 4.37	11.42 ± 3.24	0.886 (0.694–1.131)	0.330
Deep vascular skeleton density %	Parafovea	9.74 ± 4.63	11.77 ± 3.48	0.891 (0.707–1.123)	0.327
Choriocapillary flow area density mm²		1.88 ± 0.28	2.07 ± 0.14	0.019 (0.000–4.470)	0.156
Follow-up time (m)		34.33 ± 12.17	15.43 ± 14.98	1.124 (1.021–1.239)	0.017
Foveal dose (Gy)		20.50 ± 29.60	55.42 ± 110.53	1.009 (0.986–1.032)	0.445
Apex dose (Gy)		83.42 ± 9.51	87.29 ± 7.78	0.889 (0.720–1.097)	0.273

ISSN: 1471-2415